Logo Logo
Gruppieren nach: Dokumententyp | Keine Gruppierung
Anzahl der Artikel: 5.

Artikel (Klinikum der LMU)

Resuli, Blerina; Walter, Julia; Völter, Friederike; Kauffmann-Guerrero, Diego; Dahlmann, Paul; Hirner, Raphael; Unterrainer, Lena; Mertsch, Pontus; Arnold, Paola; Mras, Paula; Leuschner, Gabriela; Rübenthaler, Johannes; Schneider, Christian; Behr, Jürgen; Tufman, Amanda (2026): Baseline 18F-FDG PET/CT metabolic parameters and systemic inflammatory markers in advanced NSCLC treated with first-line immunotherapy: an exploratory retrospective analysis. Frontiers in Oncology, 16: 1837219. ISSN 2234-943X

Walter, Julia; Resuli, Blerina; Sellmer, Laura; Kauffmann-Guerrero, Diego; Bolt, Toki; Eze, Chukwuka; Behr, Jürgen; Tufman, Amanda (2025): Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis. BMC Public Health, 25: 2588. ISSN 1471-2458

Völter, Friederike; Wehlte, Lukas; Resuli, Blerina; Walter, Julia; Daisenberger, Lea; Ingenerf, Maria; Heimer, Maurice; Brendel, Matthias; Sheikh, Gabriel T.; Unterrainer, Lena M.; Kauffmann-Guerrero, Diego; Pfluger, Thomas; Heinzerling, Lucie; Tufman, Amanda (2025): Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor–related pneumonitis in lung cancer patients. Frontiers in Oncology, 15: 1563030. ISSN 2234-943X

Resuli, Blerina; Galarza, Heidi; Kauffmann-Guerrero, Diego; Oversohl, Julian; Behr, Jürgen; Tufman, Amanda (2025): Safety and efficacy of the combination of selpercatinib with osimertinib in NSCLC: a case report and review of the literature. Frontiers in Oncology, 15: 1580322. ISSN 2234-943X

Resuli, Blerina; Galarza, Heidi; Elsner, Laura; Kauffmann-Guerrero, Diego; Behr, Jürgen; Tufman, Amanda (2025): Safety of brigatinib following alectinib-induced-pneumonitis: Case report. Respiratory Medicine Case Reports, 53: 102160. ISSN 22130071

Diese Liste wurde am Mon Oct 19 21:02:11 2026 CEST erstellt.